Michael Roehrl, MD, PhD, MBA, Joins BIDMC as Chief of Pathology
Written by: Chloe Meck email@example.com
APRIL 03, 2023
BOSTON – Michael Roehrl, MD, PhD, MBA, has joined Beth Israel Deaconess Medical Center (BIDMC) as Chief of the Department of Pathology. Roehrl will lead the department’s clinical services, research and education programs.
“We are pleased to welcome Dr. Roehrl, an outstanding researcher, clinician and educator, to BIDMC,” said Pete Healy, president of BIDMC. “We are confident that his thoughtful leadership and vision will continue to propel the Department of Pathology forward.”
Prior to joining BIDMC, Roehrl served as director of the Precision Pathology Center at New York’s Memorial Sloan Kettering Cancer Center and as professor of pathology and laboratory medicine and professor of cell and developmental biology at Weill Cornell Medical School in New York City. His clinical practice and research are focused on gastrointestinal pathology. Roehrl runs an NIH-funded research lab that uses proteomics and proteogenomics to study cancer biology and autoimmunity. His lab develops protein-based biomarkers with the goal of creating next generation diagnostics and theranostics for the benefit of patients. He is also chair of the Pathology Pillar of the Human Proteome Organization.
"I am humbled and honored to join BIDMC and looking forward to working with this outstanding multidisciplinary team,” said Roehrl. “Together, we will continue to advance and innovate the practice of pathology and laboratory medicine to provide extraordinary care for our patients.”
Roehrl will succeed Jeffrey Saffitz, MD, PhD, who will continue to commit his time to treating patients, as well as his ongoing research and teaching efforts at BIDMC.
“As we welcome Dr. Roehrl to BIDMC, we also want to offer our sincere thanks to Dr. Saffitz for his 18 years of dedication to and extraordinary leadership of the Department of Pathology,” said Alexa Kimball, MD, MPH, president and CEO of Harvard Medical Faculty Physicians. “We look forward to working with them both as the department continues to advance the field of Pathology.”
Roehrl is board-certified in anatomic pathology, laboratory medicine and clinical informatics. He earned his medical degree from the Technical University of Munich in Germany and his PhD in biological chemistry from Harvard University. He holds an MBA in healthcare management from Brandeis University.
About Beth Israel Deaconess Medical Center
Beth Israel Deaconess Medical Center is a leading academic medical center, where extraordinary care is supported by high-quality education and research. BIDMC is a teaching affiliate of Harvard Medical School, and consistently ranks as a national leader among independent hospitals in National Institutes of Health funding. BIDMC is the official hospital of the Boston Red Sox.
Beth Israel Deaconess Medical Center is a part of Beth Israel Lahey Health, a health care system that brings together academic medical centers and teaching hospitals, community and specialty hospitals, more than 4,800 physicians and 38,000 employees in a shared mission to expand access to great care and advance the science and practice of medicine through groundbreaking research and education.